| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |